FSLY vs SAIC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Fastly exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. Despite a massive 407.9% one-year price surge, the stock is trading at a significant premium with a Forward P/E of 80.91 and a current price ($29.46) nearly 84% above the analyst target price of $16.00. Heavy insider selling and a bearish technical trend suggest that the recent price action is speculative rather than fundamentally driven. The company remains unprofitable with a -19.50% profit margin, making the current valuation unsustainable.
SAIC presents a conflicted profile with a Piotroski F-Score of 4/9, indicating stable but non-improving financial health. The stock is currently trading at a significant premium to both its Graham Number ($76.85) and Intrinsic Value ($53.90), suggesting it is overvalued based on deterministic models. While the company maintains a strong ROE of 23.27% and a consistent track record of beating earnings estimates, this is offset by negative YoY revenue (-4.80%) and earnings growth (-6.20%). The bearish technical trend and high debt-to-equity ratio further temper the outlook.
Compare Another Pair
Related Comparisons
FSLY vs SAIC: Head-to-Head Comparison
This page compares Fastly, Inc. (FSLY) and Science Applications International Corporation (SAIC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.